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17b-Estradiol Enhances the Production of Nerve Growth Factor
in THP-1-Derived Macrophages or Peripheral Blood Monocyte-
Derived Macrophages
Naoko Kanda and Shinichi Watanabe
Department of Dermatology,Teikyo University, School of Medicine,Tokyo, Japan
We examined in vitro e¡ects of 17b-estradiol (E2) on
nerve growth factor production by macrophages de-
rived from monocytic cell line THP-1-or periphereal
blood monocytes. E2 and membrane-impermeable bo-
vine serum albumin-conjugated E2 (E2-BSA) enhanced
nerve growth factor secretion and mRNA expression in
both types of macrophages E2 enhanced nerve growth
factor promotor activity in THP-1-derived macro-
phages and two activator protein-1 binding sites on the
promoter were responsible for the enhancement. E2
and E2-BSA enhanced transcriptional activity and
DNA binding of activator protein-1. E2 and E2-BSA
shifted the activator protein-1 composition from c-Jun
homodimers to c-Fos/c-Jun heterodimers. E2 and E2-
BSA transiently induced c-Fos mRNA, which was con-
stitutively undetectable in both types of macrophages.
Adenylate cyclase inhibitor SQ22536 suppressed E2-
induced nerve growth factor production and c-Fos
expression. E2 and E2-BSA increased intracellular cyc-
lic adenosine monophosphate level in both types of
macrophages. Antisense oligonucleotide against guanine
nucleotide-binding protein-coupled receptor, GPR30
suppressed the E2-induced cyclic adenosine monopho-
sphate signal, c-Fos expression, and nerve growth factor
secretion in both types of macrophages. These results
suggest that E2 may enhance nerve growth factor pro-
duction by inducing c-Fos expression via cyclic adenosine
monophosphate signal in macrophages. These e¡ects
may be mediated via GPR30. Key words: activator protein-1/
cyclic adenosine monophosphate/c-Fos/GPR30. J Invest Der-
matol 121:771 ^780, 2003
N
erve growth factor (NGF) accelerates skin wound
healing (Matsuda et al, 1998). NGF potentiates the
proliferation of neurons, which may promote
reinnervation in the wound (Matsuda et al, 1998).
NGF also enhances the growth of keratinocytes
(Di Marco et al, 1993; Pincelli et al, 1994), which may promote re-
epithelialization in the wound (Matsuda et al, 1998). In the in£am-
matory phase of wound healing, macrophages migrate to the
wound site, and produce a variety of growth factors, which stimu-
late collagen deposition, epithelialization, and angiogenesis, such as
platelet-derived growth factor, transforming growth factor-b, or
vascular endothelial growth factor (Moulin, 1995). Macrophages
in the wound produce neurotrophic factors inducing reinnervation
(Batchelor et al, 1999) and also secrete NGF (Caroleo et al, 2001).
Previous studies suggest that estrogen may promote wound
healing by promoting the production of basic ¢broblast growth
factor (Rider et al, 1997) or transforming growth factor-b in
the wound (Ashcroft et al, 1997). It is thus plausible that estrogen
may upregulate NGF production by macrophages in the skin
wound. Previous studies reported the modulatory e¡ects of estro-
gen on NGF production; however, the e¡ects di¡er with tissue
types or experimental conditions; estrogen in vivo increased
NGF mRNA and protein levels in murine uterus and salivary
gland, whereas it did not alter those in the bladder (Bjorling
et al, 2002). Estrogen in vitro decreased NGF protein level but did
not alter its mRNA level in murine L929 ¢broblasts (Siminoski
et al, 1987).
It is known that estrogen manifests its e¡ects by two di¡erent
mechanisms, genomic e¡ects and nongenomic e¡ects. The for-
mer is that estrogen-bound nuclear estrogen receptor (ER) a or
b upregulates or downregulates gene expression by binding to
the estrogen response element (ERE) of the target genes or by
interacting with other transcription factors, such as nuclear fac-
tor-kB (Beato, 1989; Kanda and Watanabe, 2003). On the other
hand, in the latter case, estrogen interacts with cell surface bind-
ing sites and rapidly induces a variety of intracellular signals
(Kelly and Levin, 2001); estrogen activates adenylate cyclase (AC)
(Aronica et al, 1994), phospholipase C (Razandi et al, 1999), or
extracellular signal-regulated kinase (ERK) (Migliaccio et al,
1996), or induces Ca2þ signal (Benten et al, 2001). These non-
genomic signaling events by estrogen may also lead to the upregu-
lation or downregulation of certain gene expression. Membrane
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estrogen-binding sites do not appear to be a unique molecule;
some may be post-translationally modi¢ed forms of nuclear ERa
or ERb, whereas others may be structurally di¡erent from classical
nuclear ER (Papas et al, 1995; Razandi et al, 1999; Benten et al, 2001).
It is reported that estrogen can interact with several guanine nu-
cleotide-binding protein (G-protein)-coupled receptors such as
the steroid hormone-binding globulin (SHBG) receptor (Fissore
et al, 1994; Nakla et al, 1994), or an orphan receptor GPR30 (Filardo
et al, 2000).
In a previous study, it was reported that 17b-estradiol (E2) en-
hanced the production of vascular endothelial growth factor
in phorbol-12-myristate-13-acetate (PMA)-di¡erentiated human
monocytic THP-1 cells, a suitable model for tissue macrophages
(Kanda and Watanabe, 2002). The results indicate that E2 may
promote angiogenesis in the wound. In this study, we examined
the e¡ects of E2 on NGF production in THP-1-derived macro-
phages and peripheral blood monocyte-derived macrophages,
much closer to tissue macrophages invading wounds.We found
that E2 potentiated NGF production in both cell types. We
further examined the precise mechanism for this e¡ect focusing
on the E2-induced signaling events.
MATERIALS AND METHODS
Reagents E2, 17b-estradiol 6-(O-carboxymethyl)oxime/bovine serum
albumin (E2-BSA), £uorescein isothiocyanate (FITC)-conjugated E2-
BSA (E2-BSA-FITC), 17a-estradiol, 4 -hydroxytamoxifen, progesterone,
dihydrotestosterone (DHT), and testosterone were purchased from Sigma
(St Louis, Missouri). ICI 182 780 was fromWako Pure Chemical Industries
(Osaka, Japan). U73122, PD98059, and SQ22536 were obtained from
Calbiochem (La Jolla, California). Antibodies used in electrophoretic
mobility shift assay (EMSA) were purchased from Santa Cruz Bio-
technology (Santa Cruz, California).
Di¡erentiation of peripheral blood monocytes and THP-1 cells,
and measurement of NGF secretion Peripheral blood mononuclear
cells were isolated from the blood of healthy adult volunteers who were
informed of the objectives and methods of this study and consented
to participate. Monocytes were separated from peripheral blood mono-
nuclear cells as described (Gee et al, 2002). Brie£y, peripheral blood
mononuclear cells were isolated by density-gradient centrifugation over
Ficoll-Hypaque (Pharmacia, Uppsala, Sweden), and T cells and B cells
were depleted using CD2 and CD19 dynabeads (Dynal Biotech, Oslo,
Norway). The T cell and B cell depleted fractions were incubated in 35
mm dish at 371C for 2 h following which nonadherent cells were
removed. The adherent cells obtained were less than 1% CD2þ and
CD19þ, and greater than 90% CD14þ as determined by £ow cytometry,
and were used as monocytes. Human monocytic THP-1 cells were
purchased from Dainippon Pharmaceutical (Osaka, Japan) and were
cultured in RPMI 1640 (Invitrogen, Grand Island, New York)
supplemented with 10% heat-inactivated fetal calf serum (Invitrogen)
supplemented with 100 U per mL penicillin G, 100 mg per mL
streptomycin, 0.25 mg B per mL amphotericin (Invitrogen). For
di¡erentiation, peripheral blood-derived monocytes or THP-1 cells were
plated on to 24-well plates at 5  105 or 2  105 cells, respectively, in
1 mL of the culture medium containing 100 nM PMA and allowed to
attach for 48 h as described (Bienkowski et al, 1989). The cells were
washed, and fed with PMA-free medium and cultured overnight. PMA
treatment promoted the adherence and induced £attened macrophage-like
morphology in both cell types. To measure NGF secretion, monocyte-
derived macrophages or THP-1-derived macrophages above were
incubated with phenol red and serum-free Dulbecco’s modi¢ed Eagle
medium and Ham’s F-12 medium (1:1 mixture) (DMEM/F-12)
(Invitrogen) for 24 h, then washed and incubated with various
concentrations of sex hormones in 1 mL of phenol red and serum-
free DMEM/F-12 for 24 h. Control cells were incubated with medium
alone. The supernatants were assayed for NGF by enzyme-linked
immunosorbent assay (Promega, Madison,Wisconsin).
Reverse transcription^polymerase chain reaction (reverse trans-
cription^PCR) Monocyte-derived macrophages or THP-1-derived
macrophages were incubated with sex hormones as above for indicated
periods, and cellular mRNA was extracted using a mRNA puri¢cation
kit (Pharmacia, Uppsala, Sweden) according to the manufacturer’s
instructions. cDNA was made from mRNA samples as described
(Tjandrawinata et al, 1997). Primers for ampli¢cation and the sizes of respec-
tive PCR products were as follows: ERa 50 -AAT-GTGTAGAGGGGC
ATGG-30 and 50 -TGATGTGGGAGAGGATAGG-30 for 296 bp; ERb, 50 -
TCCCAGCAATGTCACTAAC-30 and 50 -TCCCCACTAACCTTCCTT
T-30 for 219 bp; GPR30, 50 -TTCCAAGTGCACCTCCAGCC-30 and 50 -A
AGCGTGATTCTCCTTGAAG-30 for 314 bp; NGF, 50 -CACACTGAGG
TGCATAGCGT-30 and 50 -TGATGACCGCT-TGCTCCTGT-30 for 352 bp;
c-fos 50 -GGCTTCAACGCAGACTA CGAGG-30 and 50 -CTCCTGTCA
TGGTCTTCACAACG-30 for 340 bp; c-jun, 50 -TTCACCTTCTCTCTAA
CTGC-30 and 50 -TCACTCACTGA GCGCTCTTC-30 for 580 bp; gly-
ceraldehyde-3-phosphate dehydrogenase (GAPDH) 50 -GCAGGGGGGA
GCCAAAAGGG-30 and 50 -TGCCAGC-CCCAGCGTCAAAG-30 for 566
bp (Carmeci et al, 1997; Lane et al, 1998; Risse-Hackl et al, 1998; Vegeto et al,
2001; Iannone and de Bari, 2002; Kanda and Watanabe, 2003). PCR was
performed by one denaturing cycle of 951C for 3 min, 30 cycles of denatu-
ration at 951C for 30 s, annealing at 581C for 30 s, and extension at 721C for
30 s, and a ¢nal extension at 721C for 3 min. The PCR products were
analyzed by electrophoresis on 2.5% agarose gels and stained with
ethidium bromide, viewed by ultraviolet light. Densitometric analysis was
performed by scanning the bands into Photoshop and performing
densitometry with NIH Image Software (http://rsb.info.nih.gov/nih.image/).
Plasmids and transfections The ¢re£y luciferase reporter plasmids
driven by human NGF promoter (^600/þ 250 bp relative to the
transcriptional start site) were constructed by PCR and insertion into
pGL3 basic vector (Promega) as described (Cartwright et al, 1992; Cowie
et al, 1994), and was denoted as pNGF luc. Site-speci¢c mutation of
the promoter was created by multiple rounds of PCR using primers
with altered bases as described (Li and Kolattukudy, 1994). p4  ¢rst
activator protein-1 (AP-1)-TATA-luc and p4  second AP-1-TATA-luc
were constructed by inserting four copies of upstream AP-1
(50 -GCGTGTGACTCAGGAGT-30, consensus sequence underlined) or
downstream AP-1 (50 -AGCGGTGAGTCAGGCTG-30) from human
NGF promoter in front of TATA box upstream of ¢re£y luciferase
reporter as described (Kanda and Watanabe, 2003). Transient transfections
were performed with E¡ectene (Qiagen, Tokyo, Japan) as described
(Zellmer et al, 2001). THP-1-derived macrophages grown to 60%
con£uence in 24-well plates were incubated for 6 h in 0.7 mL serum and
phenol red-free DMEM/F-12 with 0.15 mg of pNGF luc or p4  ¢rst AP-
1-TATA-luc or p4  second AP-1-TATA-luc and 0.05 mg of SV40
promoter-linked b-galactosidase reporter vector, pCH110 (Amersham,
Arlington Heights, Illinois), premixed with enhancer, transfection bu¡er,
and E¡ectene. The transfected cells were washed and incubated with 1 mL
of serum and phenol red-free DMEM/F-12 for 18 h, then treated with
indicated concentrations of sex hormones. After 6 h, cell extracts were
prepared and luciferase activities were quanti¢ed using the luciferase assay
system (Promega). The same cell extracts were assayed for b-galactosidase
activity using chemiluminescent Galacto-Light kit (Tropix, Bedford,
Massachusetts). All readings were taken using a Lumat 9501 luminometer
(Berthold,Wildbach, Germany). The results obtained in each transfection
were normalized to b-galactosidase activity and expressed as relative
luciferase activity.
EMSA EMSA was performed as described (Cartwright et al, 1992). The
probes used were 32P-labeled annealed double-stranded DNA containing
¢rst AP-1 or second AP-1 from human NGF promoter. The sequence of
the ¢rst AP-1 probe is 50 -ATTTGGAGCGTGTGACTCAGGAGT-
ACGGGAG-30 (consensus sequence underlined) and that of second AP-1
probe is 50 -GGAGCGCAGCGGTGAGTCAGGCTGCCCCGAG-30. For
EMSA, 2 to 5 mg of nuclear protein extracts were incubated at room
temperature for 5 min with a mixture containing 6 mM HEPES (pH 7.9),
0.4 mM ethylenediamine tetraacetic acid, 125 mM KCl, 10% glycerol,
0.05 mg per mL, poly(dI-dC) 1 mM dithiothreitol, 2.5 mM sodium
pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na3VO4, 10 mM NaF,
50 mg per mL, aprotinin and 50 mg per mL leupeptin. One nanogram of
labeled probe was added and the reactions were incubated for another
20 min. In antibody supershift experiments, the nuclear extracts were
preincubated with various antibodies for 30 min before the addition of
the probe. Reactions were then fractionated on a nondenaturing 5%
polyacrylamide gel, and visualized with PhosphorImager (Molecular
Dynamics, Sunnyvale, California).
Measurement of cyclic adenosine monophosphate (cAMP) amount
Monocyte- or THP-1-derived macrophages in 24-well plates were serum
and phenol red deprived as above, and incubated with indicated
concentrations of sex hormones for the indicated duration. The medium
was discarded, and the cells were lyzed with acetate bu¡er (pH 5.8)
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containing 0.25% dodecyltrimethylammonium bromide. The cAMP
amount in the lysate was measured by enzyme-linked immunosorbent
assay (Amersham) according to the manufacturer’s instructions. The
sensitivity of the assay was 12 fmol per assay well. The intracellular cAMP
level was presented as pmol per 106 cells.
Measurement of AC activity Monocyte-derived macrophages or
THP-1-derived macrophages were cultured with sex hormones for 5 min
in 24-well plates as described above, and were homogenized in the bu¡er
containing 75 mM Tris^HCl (pH 7.4), 2 mM ethylenediamine tetraacetic
acid, 8 mM MgCl2, and centrifuged at 1000  g for 5 min and 40,000 
g for 20 min. The pellet was used as a membrane fraction for AC assays as
described (Salomon et al, 1974; Choi et al, 1992) using 1 mM [a-32P]
adenosine triphosphate (30 Ci per mmol) (Amersham) as a substrate.
Measurement of cyclic nucleotide phosphodiesterase (PDE) activity
Monocyte-derived macrophages or THP-1-derived macrophages were
homogenized as above, then sonicated on ice, and centrifuged at 30,000
 g for 15 min. PDE activity of the supernatants was assayed as described
(Robicsek et al, 1991) using 1 mM [2,8-3H] cAMP (30 Ci per mmol)
(Amersham) as a substrate.
Flow cytometry Monocyte-derived macrophages or THP-1-derived
macrophages were harvested and labeled with E2-BSA-FITC 15 mM for
1 h at room temperature. BSA-FITC was used as a control. Cells were
analyzed in a FACScan (Becton Dickinson, Sunnyvale, California) with a
sample size of 104 cells gated, and the data were processed using the
FACScan software as described (Benten et al, 1991).
Treatment with anti-sense oligodeoxynucleotides Anti-sense
oligonucleotides were synthesized as described (O’Dowd et al, 1998; Lau
et al, 2000; Taylor et al, 2001). The oligonucleotides were ERa,
50 -GACCATGACCATGACCCT-30; ERb, 50 -CATCACAGCAGGGCT-
ATA-30; GPR30, 50 -TTGGGAAGTCACATCCAT-30; random control,
50 -GATCTCAGCACGGCAAAT-30. For anti-sense experiments, monocyte-
derived macrophages or THP-1-derived macrophages were washed twice in
phosphate-bu¡ered saline, then transfected with ¢nally 0.2 mM of the
indicated oligonucleotides premixed with Oligofectamine (Invitrogen) in
serum and phenol red-free DMEM/F-12 for 4 h. The medium was
aspirated and fresh medium containing E2 was added.
RESULTS
E2, E2-BSA, and anti-estrogens enhanced NGF secretion in
THP-1-derived macrophages or monocyte-derived macro-
phages THP-1-derived macrophages constitutively secreted a
low amount of NGF (mean 7 SEM, 21.3 7 2.6 pg per mL,
n¼ 5), and the secretion was increased by E2; the stimulatory
e¡ect of E2 was manifested at 10^10 M, increased in a con-
centration-dependent manner, and was maximized at 10^8 M,
which enhanced NGF secretion 4.6-fold of controls (Fig 1a). On
the other hand, progesterone, DHT (Fig 1a), and testosterone
(data not shown) were ine¡ective. E2 stereoisomer 17a-estradiol
did not enhance the NGF secretion (Fig 1b). E2-BSA,
membrane-impermeable BSA-conjugated E2, enhanced NGF
secretion as well as E2 (Fig 1b), indicating that the e¡ect of E2
may be exerted on the membrane E2-binding sites, and not via
intracellular ER. BSA alone did not a¡ect NGF secretion. Anti-
estrogens, ICI 182 780 and 4-hydroxytamoxifen did not
counteract the e¡ects of E2 but enhanced NGF secretion in the
absence of E2 (Fig 1b). When the e¡ect of each agent on NGF
secretion was analyzed in peripheral blood monocyte-derived
macrophages (Fig 1c), the results were mostly the same as those
in THP-1-derived macrophages. Thus E2 enhanced NGF
secretion, and the e¡ect appeared to occur at the membrane
surface. We then examined if E2 may enhance NGF mRNA
expression.
E2 increased NGF mRNA levels At 3 h of incubation, E2
increased NGF mRNA level in THP-1-derived macrophages
(Fig 2a) or monocyte-derived macrophages (Fig 2b). E2-BSA,
ICI 182 780, and 4-hydroxytamoxifen increased NGF mRNA
level as well as E2, whereas progesterone, DHT (Fig 2), and
testosterone (data not shown) were ine¡ective. Thus E2
enhanced NGF production at pretranslational level. We then
examined if E2 may enhance NGF promoter activity.
E2 enhanced NGF promoter activity It is reported that
human NGF gene contained one AP-1-binding site upstream
from transcriptional start site (¢rst AP-1; ^62/^56 bp) and
another AP-1 site in ¢rst intron (second AP-1; þ 35/þ41 bp),
and these two AP-1-binding sites may act as enhancer elements
for NGF transcription (Cartwright et al, 1992) (Fig 3a). We
transiently transfected NGF promoter (^600/þ 250 bp) linked
to luciferase reporter into THP-1-derived macrophages, and the
NGF promoter activity was evaluated by relative luciferase
activity of the cell lysates. The attempt to transfect peripheral
blood monocyte-derived macrophages was unsuccessful. E2
increased NGF promoter activity by 5.1-fold of controls (Fig
3b). Membrane-impermeable E2-BSA (Fig 3b), ICI 182 780 and
4-hydroxytamoxifen (data not shown) enhanced the NGF
promoter activity as well as E2, whereas progesterone, DHT,
and testosterone were ine¡ective (data not shown). The mutation
of ¢rst or second AP-1 each reduced the basal promoter activity
and E2 or E2-BSA induced enhancement of the activity. The
mutation of both AP-1 sites completely abrogated the basal and
E2 or E2-BSA-induced promoter activities. These results suggest
that both AP-1 sites may be required for basal and E2 or E2-BSA-
induced NGF promoter activities. We then analyzed if E2 may
enhance transcriptional activities dependent on ¢rst or second
AP-1 sites.
Figure1. Dose-dependency for the e¡ects of sex hormones on NGF secretion (a) and the hormone speci¢city in the enhancement of the
secretion (b,c). (a) THP-1-derived macrophages were incubated with indicated concentrations of E2, progesterone (PRG), or dihydrotestosterone (DHT)
for 24 h. The culture supernatants were assayed for NGF secretion.Values are mean7SD of triplicate cultures. p o 0.05 versus control cultures without
hormones, by one-wayANOVAwith Dunnett’s multiple comparison test. The data shown in the ¢gure are representative of ¢ve separate experiments.THP-1-
derived macrophages (b) or monocyte-derived macrophages (c) were incubated with 10^8 M E2, 10^6 M ICI 182 780 (ICI), 10^6 M 4-hydroxytamoxifen
(4OHT), 10^7 M E2-BSA, 10^7 M BSA, or 10^8 M 17a-estradiol (17a-E2) alone or in combination for 24 h.Values are mean7SEM (n¼ 5). po 0.05 versus
control cultures with medium alone, by one-way ANOVAwith Sche¡e’s multiple comparison test.
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E2 enhanced AP-1 transcriptional activities THP-1-derived
macrophages were transiently transfected with luciferase reporter
linked to four repeats of ¢rst or second AP-1 in front of theTATA
box. E2 increased transcriptional activities of ¢rst and second AP-
1 (Fig 4). E2-BSA (Fig 4), ICI 182 780, and 4-hydroxytamoxifen
(data not shown) enhanced transcriptional activities through
both AP-1 sites as well as E2, whereas progesterone, DHT,
and testosterone were ine¡ective (data not shown). We then
examined if E2 may enhance the DNA-binding activity of AP-1.
E2 induced c-FOS/c-Jun binding to AP-1 sites THP-1-
derived macrophages were incubated with E2 or E2-BSA
for 1 h, and nuclear extracts were obtained and used for EMSA.
E2, E2-BSA (Fig 5, lanes 3 and 4), ICI 182 780, and 4-
hydroxytamoxifen (data not shown) increased the amount of
DNA-protein complex with the ¢rst AP-1-containing probe
derived from the NGF promoter. Progesterone, DHT, or
testosterone did not increase the amount of DNA-protein com-
plex (data not shown). In nuclear extracts from unstimulated
cells, anti-c-Jun did but anti-c-Fos antibody did not supershift
the complex (Fig 5, lanes 5 and 6), whereas in the extracts from
E2 (Fig 5, lanes 7 and 8) or E2-BSA, ICI 182 780, or 4-
hydroxytamoxifen-stimulated cells (data not shown), both anti-
c-Jun and anti-c-Fos antibodies supershifted the complex.
Antibodies against the other Fos family (FosB, Fra-1, Fra-2) or
Jun family (JunB, JunD) proteins or anti-ERa or anti-ERb
antibodies did not supershift the complexes by nuclear extracts
from unstimulated or E2, E2-BSA, or anti-estrogen-stimulated
cells (data not shown). The results were similar in monocyte-
derived macrophages (data not shown). These results suggest that
E2 may shift the AP-1 composition from c-Jun homodimers to c-
Fos/c-Jun heterodimers at the ¢rst AP-1 site. Similar results were
obtained by using the second AP-1-containing probe (data not
shown).
E2 induced c-Fos expression inTHP-1-derived macrophages
or monocyte-derived macrophages We then examined if E2
may enhance c-Fos or c-Jun expression inTHP-1-derived macro-
phages. E2 rapidly and transiently induced c-Fos mRNA. c-Fos
mRNAwas undetectable in unstimulated cells; however, in E2-
stimulated cells, the expression was induced at 15 min,
maximized at 30 min, reduced at 1 h, and disappeared at 3 h
(Fig 6a). c-Jun mRNA expression was constitutively detectable
and was not enhanced by E2. Kinetics of c-Fos and c-Jun
mRNA levels in monocyte-derived macrophages (Fig 6b) were
mostly the same as those in THP-1-derived macrophages. E2-
BSA, ICI 182 780, and 4-hydroxytamoxifen induced c-Fos
mRNA expression in a manner similar to that of E2, but did
not alter the c-Jun mRNA level, whereas progesterone, DHT, or
testosterone did not alter c-Fos or c-Jun mRNA expression in
both cell types (data not shown). The results indicate that E2,
E2-BSA, or anti-estrogen-induced NGF production may be
mainly attributable to the induction of c-Fos expression.
AC activation was involved in E2-induced NGF production
and c-Fos expression It is reported that E2 binding to the cell
surface activates a variety of signal-transducing enzymes: AC,
phospholipase C, or ERK (Migliaccio et al, 1996; Razandi et al,
1999).We thus aimed to de¢ne the signaling enzyme responsible
for the NGF production and c-Fos induction by E2. SQ22536, an
inhibitor of AC that catalyzes cAMP generation, counteracted the
E2-induced enhancement of NGF promoter activity (Fig 7a),
NGF secretion (Fig 7b), ¢rst AP-1 transcriptional activity
(Fig 7c), and c-Fos induction (Fig 7d) in THP-1-derived macro-
phages, whereas these were not counteracted by phospholipase C
inhibitor U73122 or ERK kinase 1 inhibitor PD98059. In
monocyte-derived macrophages, SQ22536 did but PD98059 or
U73122 did not inhibit the e¡ects of E2 on NGF secretion and
c-Fos expression (Fig 7e,f). The e¡ects of E2-BSA, ICI 182 780,
or 4-hydroxytamoxifen on NGF production, AP-1 activity, and
c-Fos induction were similarly counteracted by SQ22536 but not
by U73122 or PD98059 in both cell types (data not shown).These
results indicate that AC activation and resultant cAMP signal may
be responsible for the E2-induced NGF production and c-Fos
expression. This is supported by the fact that cAMP analog
dibutyryl cAMP enhanced NGF production and AP-1 activity
and induced c-Fos expression as well as E2 (Fig 7).
E2-induced cAMP signal We then examined if E2 may
generate cAMP signal in THP-1-derived macrophages. E2 rapid-
ly (within 5 min) increased intracellular cAMP concentra-
tion up to 4.8-fold of basal level, which was followed by gradual
decrease and recovery to the basal level at 3 h (Fig 8a).
E2-BSA, ICI 182 780, and 4-hydroxytamoxifen increased cAMP
level similarly to E2, whereas progesterone, DHT (Fig 8a), and
testosterone (data not shown) had no e¡ects. In monocyte-derived
macrophages treated with each agent, the kinetics of cAMP levels
were mostly comparable with those in THP-1-derived macro-
phages (data not shown). The cAMP increases by E2, E2-BSA,
Figure 2. The e¡ects of sex hormones on NGF mRNA expression
in THP-1-derived macrophages (a) or monocyte-derived macro-
phages (b). The cells were incubated with 10^8 M E2, 10^7 M E2-BSA,
10^6 M ICI 182 780 (ICI), 10^6 M 4-hydroxytamoxifen (4OHT), 10^8 M
progesterone (PRG), or 10^8 M DHT for 3 h mRNAwas isolated, and re-
verse transcription^PCRwas performed. (a) The intensity of the band for
NGF was corrected to that for GAPDH. The lower graph shows the cor-
rected intensities relative to that in control cells with medium alone (set as
1.0). The results shown in the ¢gure are representative of ¢ve separate ex-
periments in each cell type.
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and anti-estrogens were associated with increased activities of
cAMP-generating AC in both cell types (Fig 8b,d). These agents
did not alter the activity of cAMP-hydrolyzing PDE in THP-1-
derived macrophages (Fig 8c) and monocyte-derived
macrophages (data not shown). These results suggest that E2 may
activate AC and generate cAMP in both cell types.
Anti-sense GPR30 suppressed E2-induced cAMP signal,
NGF secretion, and c-Fos expression As membrane-imper-
meable E2-BSA generated cAMP as well as E2, E2 may act on
the cell surface of THP-1-derived macrophages or monocyte-
derived macrophages. To test the presence of membrane
estrogen-binding sites, we analyzed the binding of E2-BSA-
FITC to THP-1-derived macrophages. FACScan analysis showed
that the binding of E2-BSA-FITC occurred on 64% of the cells
(Fig 9a). This binding was speci¢c to E2, as BSA-FITC without
conjugated E2 did not adhere to THP-1-derived macrophages.
Similar results were obtained in monocyte-derived macrophages
(data not shown). It is reported that E2-induced cAMP signal is
mediated via membrane-localized ERa, ERb (Razandi et al,
1999), or GPR30 (Filardo et al, 2002). Reverse transcription^
PCR detected ERa, ERb, and GPR30 mRNA expression in
THP-1-derived macrophages (Fig 9b) and monocyte-derived
macrophages (data not shown), indicating that these receptors
localized at the membrane may mediate the E2-induced AC
Figure 3. The e¡ects of E2 on wild-type or mu-
tated NGF promoters in THP-1-derived macro-
phages. (a) Schematic representation of human NGF
promoter. The locations of two AP-1 sites are shown
with their sequences, and substituted bases for muta-
tion are indicated in italics. The nucleotide positions
are relative to the transcriptional start site. (b) THP-1-
derived macrophages were transiently transfected
with wild-type (WT) or mutated pNGF luc together
with pCH110, and incubated with medium alone, or
with 10^8 M E2 or 10^7 M E2-BSA for 6 h. Relative
luciferase activities normalized to b-galactosidase ac-
tivities were shown. The data are mean7SEM
(n¼ 4).Values at right indicate the fold induction ver-
sus basal promoter activity. po0.05 versus control va-
lues, by one-way ANOVA with Sche¡e’s multiple
comparison test.
Figure 4. The e¡ect of E2 on transcriptional activities through two
AP-1 sites.THP-1-derived macrophages were transiently transfected with
p4  ¢rst or second AP-1-TATA-luc or enhancerless pTATA-luc together
with pCH110. The cells were incubated with medium alone, or with 10^8
M E2 or 10^7 M E2-BSA for 6 h.The results are shown as relative luciferase
activities normalized to b-galactosidase activities, and represent mean7
SEM (n¼ 4).Values at right indicate the fold induction versus basal activity.
po0.05 versus control values, by one-way ANOVA with Sche¡e’s multiple
comparison test.
Figure 5. The e¡ect of E2 or E2-BSA on transcription factor bind-
ing toAP-1 sites.THP-1-derived macrophages were incubated with med-
ium alone, or with 10^8 M E2 or 10^7 M E2-BSA for 1 h. Nuclear extracts
were prepared, and incubated with 32P-labeled oligonucleotides containing
the ¢rst AP-1 element. In supershift assays, nuclear extracts were incubated
with antibodies against c-Fos or c-Jun for 30 min before the addition of the
probe. The asterisks indicate the supershifted complexes. The results shown
in the ¢gure are representative of four separate experiments.
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activation. As speci¢c antibody against GPR30 cannot be ob-
tained, we analyzed if ERa, ERb, or GPR30 anti-sense oli-
gonucleotide may inhibit E2-induced cAMP signal. GPR30
anti-sense did but ERa or ERb anti-sense did not suppress the
E2-induced cAMP signal (Fig 10a,d), NGF secretion (Fig 10b,e),
or c-Fos expression (Fig 10c,f) in THP-1-derived macrophages or
monocyte-derived macrophages. The e¡ects of E2-BSA, ICI 182
780, or 4-hydroxytamoxifen on cAMP signal, c-Fos expression,
and NGF secretion were also suppressed by GPR30 anti-sense
but not by ERa or ERb anti-sense (data not shown). These
results suggest that cell surface GPR30 may mediate the E2, E2-
BSA, and anti-estrogen-induced cAMP signal and resultant c-Fos
expression and NGF production.
DISCUSSION
In this study, E2 enhanced NGF production in monocyte-derived
macrophages or THP-1-derived macrophages. E2 stimulated
NGF promoter activity by enhancing AP-1 transcriptional
activity via c-Fos induction in THP-1-derived macrophages. The
induced c-Fos may heterodimerize with c-Jun and the hetero-
dimers may bind to two AP-1 sites on the NGF promoter and
drive NGF transcription. On the other hand, c-Jun homodimers
appeared to bind to the AP-1 sites in unstimulated cells. It is re-
ported that c-Fos/c-Jun heterodimers much more avidly bind to
DNA and have much higher transcriptional activity than c-Jun
homodimers (Allegretto et al, 1990; Suzuki et al, 1991). Thus E2
may enhance AP-1 binding and transcriptional activity by indu-
cing c-Fos expression and thus shifting AP-1 composition from
c-Jun homodimers to c-Fos/c-Jun heterodimers. Though the ef-
fects of E2 on NGF promoter or AP-1 transcriptional activities
could not be examined in monocyte-derived macrophages, rapid
c-Fos induction by E2 occurred in these cells, indicating that the
mechanism for NGF potentiation by E2 in monocyte-derived
macrophages may be common to that in THP-1-derived macro-
phages.
E2-induced c-Fos expression was mediated by cAMP signal.
Human c-fos promoter contains cAMP response element (CRE)
at ^62 bp, where CRE-binding protein (CREB) binds and
drives c-fos transcription (Fisch et al, 1989; Janknecht et al, 1995).
The transcriptional activity of CREB is promoted by serine
Figure 6. The e¡ects of E2 on c-Fos or c-Jun mRNA expression in
THP-1-derived macrophages (a) or monocyte-derived macro-
phages (b). The cells were incubated with 10^8 M E2. At indicated time-
points, mRNA was isolated, and reverse transcription^PCR was per-
formed. The results shown in the ¢gure are representative of ¢ve separate
experiments in each cell type.
Figure 7. The inhibition by several signal
modulators on E2-induced NGF promoter
activity (a), NGF secretion (b,e), AP-1 trans-
criptional activity (c), and c-Fos mRNA
expression (d,f). THP-1-derived macrophages
were transiently transfected with pNGF luc (a)
or p4  ¢rst AP-1-TATA-luc (c), together with
pCH110, then preincubated with 200 mM SQ22536,
1 mM U73122, or 20 mM PD98059 for 10 min,
then incubated with 10^8 M E2 or with 1mM dibu-
tyryl cAMP (Bt2cAMP). After 6 h, luciferase activ-
ities of the cell lysates were analyzed and were
normalized to b-galactosidase activities. THP-1-
derived macrophages (b,d) or monocyte-derived
macrophages (e,f) were preincubated with inhibi-
tors, then incubated with E2 or dibutyryl cAMP as
above. Culture supernatants were harvested after 24
h (b,e), whereas mRNAwas extracted after 30 min
(d,f). In (a,b,c,e), values are mean 7 SEM of ¢ve
separate experiments in each cell type. po0.05
versus control values, wp o 0.05 versus values with
E2 alone, by one-way ANOVAwith Sche¡e’s multiple
comparison test. The results shown in (d, f ) are
representative of ¢ve separate experiments in each
cell type.
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phosphorylation via protein kinase A, which is activated by
cAMP (Lalli and Sassone-Corsi, 1994). It is also reported that
E2-induced cAMP signal induced CREB phosphorylation and
CRE-dependent expression of neurotensin/neuromedin gene in
human neuroblastoma SK-N-SH cells (Watters and Dorsa, 1998).
In THP-1-derived macrophages or monocyte-derived macro-
phages, G-protein-coupled receptor, GPR30 appeared to act as a
membrane E2-binding site linked to AC, which is consistent
with the study performed in human breast cancer cells (Filardo
et al, 2002). GPR30 is a 375 amino acid G-protein-coupled recep-
tor with seven transmembrane domains (Carmeci et al, 1997).
GPR30 mRNA is ubiquitously expressed in brain, lung, liver,
prostate, or colon (Owman et al, 1996). The ligand for GPR30
has not been identi¢ed yet; however, it may be a certain peptide
or glycoprotein (Carmeci et al, 1997). To date, GPR30-coupling
G-protein isotypes are unknown; however, GPR30-mediated ac-
tivation of AC indicates its linkage to Gs. It is hypothesized that
the binding of E2 may activate GPR30 and induce the dissocia-
tion of the receptor-coupled G-protein heterotrimers, possibly
Gsabg, into Gsa and Gbg, the former of which may stimulate
AC catalytic activity.
Razandi et al (1999) showed that membrane ER arises from
the same transcript as that of nuclear ER, and that the stimula-
tion of membrane ERa or ERb by E2 generated the cAMP
signal in Chinese hamster ovary cells transfected with ERa
or ERb, respectively. InTHP-1-derived macrophages or monocyte-
derived macrophages, however, the contribution of membrane
ERa or ERb to the cAMP signal may be little if any as anti-sense
ERa or ERb did not inhibit the E2-induced cAMP signal
(Fig 10). Another possible membrane E2-binding site linked to
AC is the SHBG receptor (Fissore et al, 1994; Nakhla et al, 1994).
In prostate cells or breast cancer MCF-7, E2 interacts with SHBG
prebound to membrane SHBG receptor, and generates the cAMP
signal (Fissore et al, 1994; Nakhla et al, 1994). As THP-1-derived
macrophages or monocytederived macrophages were not prein-
cubated with exogenous SHBG prior to E2 incubation in this
study, the involvement of SHBG receptor in E2-induced AC ac-
tivation is rather unlikely in these cells.
In this and previous studies (Kanda and Watanabe, 2002),
anti-estrogens, ICI compounds, or tamoxifen derivatives, did not
antagonize E2-induced AC activation. ICI 182 780 and 4-hydro-
xytamoxifen rather activated AC as well as E2. The results are
Figure 8. The e¡ects of sex hormones on the intracellular cAMP level (a), AC (b,d), and PDE activities (c). (a) THP-1-derived macrophages were
incubated with medium alone, E2 (10^8 M), E2-BSA (10^7 M), BSA (10^7 M), ICI 182 780 (ICI; 10^6 M), 4-hydroxytamoxifen (4OHT; 10^6 M), progesterone
(PRG; 10^8 M), or DHT (10^8 M). The intracellular cAMP level was analyzed at the indicated time points. The mean of triplicate cultures is shown; the SD
wereo 10% of the means. The data are representative of four separate experiments. THP-1-derived macrophages (b,c) or monocyte-derived macrophages (d)
were incubated as above. After 5 min, AC (b,d) or PDE activities (c) were analyzed.The data represent the mean7 SEM of four separate experiments in each
cell type. po0.05 versus control values with medium alone, by one-way ANOVAwith Sche¡e’s multiple comparison test.
Figure 9. Flow cytometry of THP-1-derived macrophages labeled
with E2-BSA-FITC (a) and ERa, ERb, and GPR30 mRNA expres-
sion (b). (a) The cells were labeled with E2-BSA-FITC and were analyzed
by FACScan (lower panel). Controls in the upper panel shows cells incubated
with BSA-FITC. (b) Reverse transcription^PCR was performed with
cDNA fromTHP-1-derived macrophages. The results shown in the ¢gure
are representative of ¢ve separate experiments.
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consistent with previous studies (Aronica et al, 1994; Farhat et al,
1996; Watters and Dorsa, 1998; Razandi et al, 1999; Filardo et al,
2002). Though tamoxifen derivatives or ICI compounds can act
as antagonists for nuclear ER (Berry et al, 1990), these anti-estro-
gens may act as agonists for membrane GPR30.
It is reported that E2 induces human c-fos gene expression
in cells other than macrophages. The mechanisms for the induc-
tion di¡er with cell types, however; in ERa-transfected
HeLa cells, ERa drives c-fos gene expression by binding to 50 -
£anking imperfect ERE (CGGCAGCGTGACC, underlined
sequences matching to consensus ERE) at ^1212 bp (Weisz and
Rosales, 1990). In MCF-7 cells, ERa interacts with transcrip-
tion factor Sp1 and enhances its DNA binding and c-fos transcrip-
tion through the GC-rich motif at ^1168 bp (Duan et al, 1998).
These modes of c-fos transcription are mediated by nuclear
ERa, and which mechanism works in individual cell types
may depend on the amounts or subtypes (a or b) of nuclear ER
and on the amounts or activities of other transcriptional activa-
tors. On the other hand, membrane-impermeable E2-BSA in-
duced c-fos expression in SK-N-SH cells by activating ERK,
which may be mediated via membrane E2-binding sites (Watters
et al, 1997). c-fos promoter contains serum response element at ^
317 bp where ternary complex factors such as Elk1 are binding
(Gilman et al, 1986; Janknecht et al, 1995; Soh et al, 1999). It is
known that ERK-mediated phosphorylation of Elk1 promotes
its transcriptional activity (Marais et al, 1993). It is thus anticipated
that Elk1 phosphorylation by ERK may be involved in E2-BSA-
induced c-fos expression in SK-N-SH cells. E2 is reported to
transactivate epidermal growth factor receptor-Ras-Raf-1-ERK
kinase 1-ERK signaling pathway via GPR30 by releasing cell
surface heparan-bound epidermal growth factor in MCF-7
(Filardo et al, 2000). Thus a similar manner of ERK acti-
vation may occur in THP-1-derived macrophages or mono-
cyte-derived macrophages containing GPR30; however,
ERK was dispensable for E2-induced c-fos expression in
these cells (Fig 7). Possibly in THP-1-derived macrophages
or monocyte-derived macrophages, cAMP-activated pro-
tein kinase A may attenuate ERK activation by inhibiting
the activity of Raf-1, which phosphorylates and activates ERK
kinase 1, catalyzing ERK phosphorylation (Filardo et al, 2002).
In contrast to c-Fos, c-Jun mRNA level was not increased by
E2 (Fig 6). It is reported that E2 increased c-jun expression in rat
uterine myometrium (Nephew et al, 1994). The coding sequence
of the rat c-jun gene contains an imperfect ERE (Hyder et al,
1995) and a similar element is also conserved in the human gene
(ACAGAGCATGACC) (Hattori et al, 1988); however, ER bind-
ing a⁄nity and E2-induced transcriptional activity of such im-
perfect ERE were much lower than those of consensus ERE
(GGTCAnnnTGACC). InTHP-1-derived macrophages or mono-
cyte-derived macrophages, this imperfect ERE in c-jun gene may
not function as an E2-inducible enhancer element.
E2 stimulated NGF production not only in THP-1-derived
macrophages but also in peripheral blood monocyte-derived
macrophages, which are closer to macrophages invading wounds.
This suggests that topical application of E2 to wounds may en-
hance NGF production by invading macrophages. NGF induc-
tion by E2 in macrophages may accelerate wound repair in an
autocrine and paracrine manner. As NGF promotes the survival,
di¡erentiation, and phagocytosis of macrophages (Caroleo et al,
2001), macrophage-derived NGF may maintain the number of
macrophages and enhance their elimination of bacteria or cell
debris, which is required for rapid wound repair. The application
of E2 to wound site may promote the proliferation and migra-
tion of keratinocytes and neural cells via NGF induction in
macrophages, and thus accelerate re-epithelialization and reinner-
vation required for wound healing. NGF also induces neurons to
synthesize a neuropeptide substance P, which stimulates the pro-
liferation of keratinocytes, ¢broblasts, and endothelial cells and
thus promotes ¢broplasia, re-epithelialization, and angiogenesis
at the wound site (Linsay and Harmar, 1989; Ansel et al, 1996).
Skin wound healing is impaired in sensory nerve-de¢cient con-
ditions, such as diabetes, leprosy, or aging (Khalil et al, 1994; Ansel
et al, 1996; Khalil and Merhi, 2000), and in such states, skin NGF
content is reduced (Anand et al, 1994, 1996). Thus E2 may be ther-
apeutically useful in the impaired wound healing associated with
sensory nerve de¢cits by inducing NGF. It is also reported that
E2 enhances high-a⁄nity NGF receptor trkA expression in neu-
ral cells (Sohrabji et al, 1994), indicating that E2 may promote
responsiveness to NGF in addition to NGF production. As NGF
is produced by many cell types other than macrophages, such
as keratinocytes, ¢broblasts, or mast cells (Kinkelin et al,
2000), further studies should elucidate if E2 may enhance NGF
production in these cells by mechanisms similar to or di¡erent
from that in macrophages.
Figure10. The inhibition by GPR30 anti-sense oligonucleotide of E2-induced cAMP signal (a,d), NGF secretion (b,e), and c-Fos expression
(c,f). THP-1-derived macrophages (a^c) or monocyte-derived macrophages (d^f) were pretreated with 0.2 mM of indicated anti-sense (AS) or control
scrambled oligonucleotides (ODN) for 4 h. The medium was aspirated and fresh medium containing E2 10^8 M was added. The intracellular cAMP level
was analyzed at 5 min (a,d), NGF secretion was analyzed at 24 h (b,e), and c-Fos mRNA expression was analyzed at 30 min (c,f). In (a,b,d,e), values are mean
7 SEM of ¢ve separate experiments in each cell type. po0.05 versus control values, wpo 0.05 versus values with E2 alone, by one-wayANOVAwith Sche¡e’s
multiple comparison test. The results shown in (c,f ) are representative of ¢ve separate experiments in each cell type.
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